Who Owns VINC?

VINCERX PHARMA INC — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

$68K

Shares Outstanding

Institutional Holders

14

Total Inst. Value

$63K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CITADEL ADVISORS LLC$23K42,777
2GOLDMAN SACHS GROUP INC$17K31,567
3GEODE CAPITAL MANAGEMENT, LLC$9K19,285
4TWO SIGMA SECURITIES, LLC$6K11,053
5MILLENNIUM MANAGEMENT LLC$6K10,798
6Tower Research Capital LLC (TRC)$2K2,997
7BlackRock, Inc.$1K2,352
8UBS Group AG$75142
9SAGE RHINO CAPITAL LLC$4585,170
10SBI Securities Co., Ltd.$2650

Related Stocks

Frequently Asked Questions

How many institutional investors hold VINC?

As of Q1 2025, 14 institutional investors report holding VINC (VINCERX PHARMA INC) in their 13F filings.

Which hedge fund owns the most VINC?

The largest institutional holder of VINC is CITADEL ADVISORS LLC with $23K in shares.

Are institutions buying or selling VINC?

This quarter, 14 institutions opened new positions in VINC and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.